Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica–Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Kumar, B. N. Prashanth Puvvada, Nagaprasad Rajput, Shashi Sarkar, Siddik Mahto, Madhusudan Kr Yallapu, Murali M. Pathak, Amita Emdad, Luni Das, Swadesh K. Reis, Rui L. Kundu, S. C. Fisher, Paul B. Mandal, Mahitosh

Journal title: Molecular Pharmaceutics

Journal publisher: American Chemical Society

Published year: 2018

Published pages: 2698-2713

DOI identifier: 10.1021/acs.molpharmaceut.8b00218

ISSN: 1543-8384